Your browser doesn't support javascript.
loading
Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials.
Hongell, Kira; Silva, Diego G; Ritter, Shannon; Meier, Daniela Piani; Soilu-Hänninen, Merja.
Afiliación
  • Hongell K; Division of Clinical Neurosciences, Turku University Hospital and University of Turku, PB 52, 20521, Turku, Finland. kira.hongell@utu.fi.
  • Silva DG; Novartis Pharma AG, Fabrikstrasse 12, 4056, Basel, Switzerland.
  • Ritter S; Novartis Pharmaceuticals Corporation, One Health Plaza, Bldg. 200, Office 238, East Hanover, NJ, 07936-1080, USA.
  • Meier DP; Novartis Pharma AG, Fabrikstrasse 12, 4056, Basel, Switzerland.
  • Soilu-Hänninen M; Division of Clinical Neurosciences, Turku University Hospital and University of Turku, PB 52, 20521, Turku, Finland.
J Neurol ; 265(2): 348-355, 2018 Feb.
Article en En | MEDLINE | ID: mdl-29243005
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitamina D / Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod / Inmunosupresores Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Año: 2018 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitamina D / Esclerosis Múltiple Recurrente-Remitente / Clorhidrato de Fingolimod / Inmunosupresores Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Año: 2018 Tipo del documento: Article País de afiliación: Finlandia